| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.962 | 0.002 | 0.962 | Histone deacetylase inhibitor | 0.37 0.004 DBMET01414 | ||
| 0.945 | 0.001 | 0.945 | Histone deacetylase class I inhibitor | 0.271 0.004 DBMET01414 | ||
| 0.933 | 0.001 | 0.933 | Histone deacetylase 8 inhibitor | 0.5 0.003 DBMET01414 | ||
| 0.768 | 0.001 | 0.768 | Histone deacetylase 9 inhibitor | 0.36 0.002 DBMET01414 | ||
| 0.761 | 0.001 | 0.761 | Histone deacetylase 7 inhibitor | 0.424 0.002 DBMET01414 | ||
| 0.761 | 0.021 | 0.761 | Apoptosis agonist | 0.369 0.129 DBMET01414 | ||
| 0.734 | 0.003 | 0.89 | Histone deacetylase 3 inhibitor | 0.89 0.002 DBMET01414 | DBMET01414 | |
| 0.706 | 0.003 | 0.706 | Histone deacetylase 1 inhibitor | 0.663 0.003 DBMET01414 | ||
| 0.66 | 0.012 | 0.66 | Antibacterial | 0.577 0.023 DBMET01414 | ||
| 0.635 | 0.004 | 0.635 | Cathepsin G inhibitor | |||
| 0.634 | 0.003 | 0.634 | Histone acetyltransferase inhibitor | |||
| 0.634 | 0.003 | 0.638 | Histone deacetylase 2 inhibitor | 0.638 0.003 DBMET01414 | DBMET01414 | |
| 0.575 | 0.003 | 0.575 | Histone deacetylase 11 inhibitor | 0.266 0.004 DBMET01414 | ||
| 0.575 | 0.003 | 0.575 | Histone deacetylase class IV inhibitor | 0.266 0.004 DBMET01414 | ||
| 0.594 | 0.055 | 0.594 | Antiinflammatory | |||
| 0.516 | 0.004 | 0.516 | Antineoplastic antibiotic | 0.22 0.018 DBMET01414 | ||
| 0.474 | 0.014 | 0.474 | Antimitotic | |||
| 0.478 | 0.027 | 0.478 | Immunomodulator | 0.194 0.171 DBMET01414 | ||
| 0.461 | 0.014 | 0.461 | Interleukin 2 agonist | 0.214 0.166 DBMET01414 | ||
| 0.408 | 0.003 | 0.408 | Chymotrypsin inhibitor | 0.071 0.069 DBMET01414 | ||
| 0.439 | 0.05 | 0.547 | Immunosuppressant | 0.547 0.021 DBMET01414 | DBMET01414 | |
| 0.403 | 0.048 | 0.403 | Antithrombotic | |||
| 0.351 | 0.004 | 0.358 | Histone deacetylase class IIb inhibitor | 0.358 0.004 DBMET01414 | DBMET01414 | |
| 0.349 | 0.004 | 0.349 | ErbB-3 antagonist | 0.073 0.072 DBMET01414 | ||
| 0.338 | 0.004 | 0.341 | Histone deacetylase 6 inhibitor | 0.341 0.004 DBMET01414 | DBMET01414 | |
| 0.335 | 0.003 | 0.335 | Histone deacetylase 4 inhibitor | 0.201 0.004 DBMET01414 | ||
| 0.314 | 0.003 | 0.314 | Nav1.4 sodium channel blocker | |||
| 0.251 | 0.005 | 0.251 | Factor XII inhibitor | |||
| 0.246 | 0.003 | 0.246 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.228 | 0.004 | 0.228 | Histone deacetylase class II inhibitor | 0.222 0.004 DBMET01414 | ||
| 0.22 | 0.004 | 0.22 | Histone deacetylase class IIa inhibitor | 0.12 0.007 DBMET01414 | ||
| 0.228 | 0.014 | 0.228 | Microtubule formation inhibitor | |||
| 0.215 | 0.004 | 0.215 | Oxytocin antagonist | |||
| 0.24 | 0.036 | 0.24 | Thrombolytic | |||
| 0.218 | 0.036 | 0.218 | Protein kinase stimulant | |||
| 0.228 | 0.049 | 0.228 | P-glycoprotein inhibitor | |||
| 0.187 | 0.008 | 0.187 | Somatostatin 1 agonist | |||
| 0.169 | 0.004 | 0.169 | Elastase inhibitor | |||
| 0.167 | 0.005 | 0.167 | Elastase 1 inhibitor | |||
| 0.269 | 0.109 | 0.269 | Sodium/bile acid cotransporter inhibitor | |||
| 0.159 | 0.006 | 0.159 | Histone deacetylase 5 inhibitor | 0.087 0.011 DBMET01414 | ||
| 0.157 | 0.005 | 0.157 | Somatostatin 1 antagonist | |||
| 0.154 | 0.005 | 0.154 | Leukocyte elastase inhibitor | |||
| 0.15 | 0.004 | 0.15 | Antidiuretic hormone agonist | |||
| 0.133 | 0.005 | 0.133 | Somatostatin 2 antagonist | |||
| 0.136 | 0.008 | 0.136 | Antidiuretic hormone antagonist | |||
| 0.129 | 0.003 | 0.129 | Kallikrein 7 inhibitor | |||
| 0.118 | 0.005 | 0.118 | Growth hormone release inhibitor | |||
| 0.118 | 0.005 | 0.118 | Somatostatin 5 antagonist | |||
| 0.116 | 0.009 | 0.116 | Kallikrein inhibitor | |||
| 0.11 | 0.005 | 0.11 | Somatostatin 4 antagonist | |||
| 0.149 | 0.047 | 0.149 | Proteasome inhibitor | |||
| 0.115 | 0.015 | 0.115 | Plasmin inhibitor | |||
| 0.097 | 0.004 | 0.097 | Cyclophilin A inhibitor | |||
| 0.096 | 0.004 | 0.096 | Vasopressin 2 agonist | |||
| 0.113 | 0.025 | 0.113 | ATPase (Vacuolar H+) inhibitor | 0.113 0.025 DBMET01414 | ||
| 0.094 | 0.006 | 0.094 | Vasopressin 2 antagonist | |||
| 0.097 | 0.023 | 0.097 | Glucagon-like peptide 1 agonist | |||
| 0.106 | 0.036 | 0.106 | Acetylcholine nicotinic antagonist | |||
| 0.074 | 0.005 | 0.074 | Somatostatin 3 antagonist | |||
| 0.084 | 0.025 | 0.084 | Trypsin inhibitor | |||
| 0.157 | 0.102 | 0.175 | Hepatoprotectant | 0.175 0.084 DBMET01414 | DBMET01414 | |
| 0.067 | 0.012 | 0.067 | Vasopressin 1 antagonist | |||
| 0.062 | 0.009 | 0.062 | Somatostatin 5 agonist | |||
| 0.073 | 0.022 | 0.073 | Kallikrein 1 inhibitor | |||
| 0.05 | 0.003 | 0.05 | Vasopressin 1A agonist | |||
| 0.062 | 0.017 | 0.062 | Erythropoietin receptor agonist | |||
| 0.056 | 0.012 | 0.056 | Vasopressin 1A antagonist | |||
| 0.044 | 0.003 | 0.044 | Vasopressin 1 agonist | |||
| 0.045 | 0.008 | 0.045 | Growth factor receptor-bound protein 2 antagonist | |||
| 0.043 | 0.009 | 0.043 | Vasopressin 1B antagonist | |||
| 0.087 | 0.056 | 0.087 | Hematopoietic | |||
| 0.044 | 0.014 | 0.06 | Histone deacetylase 10 inhibitor | 0.06 0.009 DBMET01414 | DBMET01414 | |
| 0.07 | 0.045 | 0.07 | Neuronal nicotinic receptor antagonist | |||
| 0.032 | 0.01 | 0.032 | 1,3-Beta-glucan synthase inhibitor | |||
| 0.032 | 0.013 | 0.032 | Motilin receptor antagonist | |||
| 0.022 | 0.003 | 0.022 | Immunosuppressant Cyclosporine-like | 0.012 0.007 DBMET01414 | ||
| 0.031 | 0.013 | 0.031 | Growth hormone releasing factor antagonist | |||
| 0.016 | 0.004 | 0.016 | Calcineurin inhibitor | |||
| 0.045 | 0.035 | 0.045 | Microtubule stabilization | |||
| 0.027 | 0.018 | 0.027 | Urotensin II agonist | |||
| 0.022 | 0.013 | 0.022 | Integrin beta5 antagonist | |||
| 0.054 | 0.046 | 0.054 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.098 | 0.095 | 0.098 | Acetylcholine antagonist | |||
| 0.088 | 0.084 | 0.088 | Nav1.1 sodium channel blocker | |||
| 0.099 | 0.096 | 0.099 | Cholinergic antagonist | |||
| 0.028 | 0.025 | 0.028 | Somatostatin agonist | |||
| 0.131 | 0.13 | 0.131 | Platelet adhesion inhibitor | |||
| 0.148 | 0.168 | 0.323 | Antioxidant | 0.323 0.054 DBMET01414 | DBMET01414 | |
| 0.131 | 0.251 | 0.459 | Transcription factor NF kappa B inhibitor | 0.459 0.051 DBMET01414 | DBMET01414 | |
| 0.027 | 0.193 | 0.068 | Angiotensin-converting enzyme inhibitor | 0.068 0.021 DBMET01414 | DBMET01414 | |
| 0.078 | 0.246 | 0.146 | Nitric oxide antagonist | 0.146 0.098 DBMET01414 | DBMET01414 | |
| 0.06 | 0.241 | 0.272 | Angiogenesis stimulant | 0.272 0.061 DBMET01414 | DBMET01414 | |
| 0.067 | 0.313 | 0.289 | Free radical scavenger | 0.289 0.055 DBMET01414 | DBMET01414 | |
| 0.004 | 0.344 | 0.052 | HMG CoA reductase inhibitor | 0.052 0.006 DBMET01414 | DBMET01414 | |
| 0.025 | 0.527 | 0.389 | Interleukin antagonist | 0.389 0.032 DBMET01414 | DBMET01414 | |
| 0.027 | 0.678 | 0.555 | Transcription factor inhibitor | 0.555 0.06 DBMET01414 | DBMET01414 | |
| 0.009 | 0.741 | 0.219 | Hypolipemic | 0.219 0.083 DBMET01414 | DBMET01414 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |